CAM
MRK icon

Cresset Asset Management’s Merck MRK Stock Holding History

Cresset Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.9M Buy
263,545
+17,397
+7% +$2.01M 0.14% 101
2025
Q4 		$26.1M Buy
246,148
+2,143
+0.9% +$201K 0.11% 112
2025
Q3 		$20.7M Buy
244,005
+7,062
+3% +$582K 0.09% 133
2025
Q2 		$18.9M Sell
236,943
-62,684
-21% -$4.98M 0.09% 132
2025
Q1 		$27.1M Sell
299,627
-1,539
-0.5% -$144K 0.14% 103
2024
Q4 		$30.2M Sell
301,166
-139,386
-32% -$14.4M 0.14% 95
2024
Q3 		$50.3M Sell
440,552
-14,969
-3% -$1.78M 0.19% 77
2024
Q2 		$56.7M Buy
455,521
+48,796
+12% +$6.29M 0.24% 63
2024
Q1 		$54M Buy
406,725
+40,134
+11% +$4.95M 0.26% 54
2023
Q4 		$40.2M Sell
366,591
-906
-0.2% -$94K 0.24% 61
2023
Q3 		$38.1M Buy
367,497
+9,268
+3% +$999K 0.15% 76
2023
Q2 		$41.6M Buy
358,229
+263,179
+277% +$29.9M 0.05% 115
2023
Q1 		$10.2M Sell
95,050
-104,106
-52% -$11.2M 0.2% 75
2022
Q4 		$19.2M Sell
199,156
-8,368
-4% -$855K 0.24% 54
2022
Q3 		$18M Sell
207,524
-2,006
-1% -$179K 0.23% 49
2022
Q2 		$19.1M Buy
209,530
+2,123
+1% +$188K 0.23% 47
2022
Q1 		$17.1M Sell
207,407
-2,963
-1% -$234K 0.18% 57
2021
Q4 		$16.3M Buy
210,370
+7,823
+4% +$623K 0.16% 65
2021
Q3 		$15.3M Buy
202,547
+2,703
+1% +$206K 0.21% 44
2021
Q2 		$15.7M Sell
199,844
-1,016
-0.5% -$75.6K 0.22% 42
2021
Q1 		$14.9M Buy
200,860
+932
+0.5% +$68.7K 0.24% 40
2020
Q4 		$15.7M Sell
199,928
-31,452
-14% -$2.41M 0.26% 37
2020
Q3 		$18.4M Buy
231,380
+3,070
+1% +$240K 0.34% 29
2020
Q2 		$17M Buy
228,310
+36,776
+19% +$2.77M 0.37% 28
2020
Q1 		$14.2M Buy
191,534
+15,953
+9% +$1.25M 0.43% 29
2019
Q4 		$15.3M Buy
175,581
+5,850
+3% +$480K 0.42% 26
2019
Q3 		$13.7M Buy
169,731
+10,502
+7% +$842K 0.42% 30
2019
Q2 		$12.8M Buy
159,229
+9,228
+6% +$707K 0.4% 36
2019
Q1 		$12M Buy
150,001
+42,936
+40% +$3.21M 0.46% 22
2018
Q4 		$7.86M Buy
+107,065
New +$7.56M 0.47% 23

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cresset Asset Management's MRK Position: Q1 2026 in Review

Cresset Asset Management increased its Merck (MRK) stake by 7.1% in Q1 2026, buying an estimated $2.01M and bringing the position to 263,545 shares worth $31.9M. The position accounts for 0.14% of the portfolio, ranked #101.

Cresset Asset Management first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $56.7M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cresset Asset Management held 263,545 shares of Merck worth $31.9M as of Q1 2026.
  • Cresset Asset Management bought 17,397 Merck shares in Q1 2026, an estimated $2.01M.
  • Merck made up 0.14% of Cresset Asset Management's portfolio in Q1 2026, its #101 holding.
  • Cresset Asset Management first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Merck position peaked at $56.7M in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.